Our Partners
We collaborate with academia, life sciences, insurances and healthcare providers to deliver solutions for the longevity industry
Copenhagen University Hospital
Hvidovre Hospital is a hospital in the greater Copenhagen area, Denmark. It is one of Denmark's largest hospitals with about 5600 employees, with more than 95.000 patients admitted and 595.000outpatient visits in 2021. It has 35 departments, including Denmark's largest delivery ward with more than 7000 deliveries a year. Hvidovre hospital is part of Copenhagen University Hospital, a conglomerate of several hospitals from the Capital Region and Zealand Region, together with the Faculty of Health and Medical Sciences at the University of Copenhagen. The hospital is a teaching hospital for medical students. Strong clinical research is one of the hospital's pillars. The Department of Clinical Research performs research on the patients’ paths during and after admission, to optimize treatments, with special emphasis on older people with chronic diseases, multimorbid patients with polypharmacy, and people that are acutely admitted to the hospital.
BioFi
BioFi transforms the way we understand biology. BioFi’s proprietary technology CellSim™ provides virtual modeling and simulation solutions for living organisms. From single cell bacteria to developed cancers, starting with simulated biological building blocks, CellSim™ enables the development and growth of virtual cells and tissues. These virtual cells and tissues enable versatile experimentation to investigate biological mechanisms and make predictions. Applications include drug discovery and development and synthetic biology.
DR. MED. MICHAEL D. WAGENER
Michael Wagener is a board certified general internist and Doctor of Pharmaceutical Medicine. He owns additional training in neuraltherapy, orthomolecular medicine and is external Employee at the Department of Clinical Pharmacology at the University of Zurich.
The focus of his clinic (DR.WAGENER) is the integrative treatment approach of chronic diseases and now the establishment of a treatment strategies and concepts in Longevity Medicine.
In addition he works as a medical consultant and lecturer for various companies and institutions. He is a member of the Board of the SSAAMP (Swiss Society for Antiaging medicine and prevention). Since 2022 he is a member of the scientific advisory board of the Quant Biomarkers company.
PXM - Precise x Med
PXM is an innovation and business strategy partner for digital health solutions and to assist life sciences software and health technology companies to be disruptive in the healthcare industry .
